Ana Maria Carvalho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ana Maria Carvalho has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Pedro Sá Almeida
Internal Medicine, Unidade Local de Saúde de Trás-os-Montes e Alto Douro, Chaves, PRT
3 shared publicationsRita G Magalhães
Internal Medicine, Unidade Local de Saúde de Trás-os-Montes e Alto Douro, Chaves, PRT
2 shared publicationsAna Maria Carvalho Sr.
1 shared publicationBeatriz Exposito
Internal Medicine, Unidade Local de Saúde de Trás-os-Montes e Alto Douro, Chaves, PRT
1 shared publicationJoana Cunha
Internal Medicine Unidade Local de Saúde de Trás-os-Montes e Alto Douro Chaves
1 shared publicationJoão Enes Silva
Internal Medicine, Unidade Local de Saúde de Trás-os-Montes e Alto Douro, Chaves, PRT
1 shared publication
Latest Publications
- Open Access
- 16 February 2026
- Published by Springer Nature in Cureus
- Vol. 18 (2)
Giant Arachnoid Cyst Presenting With Transient Facial Paresthesia: A Case Report
Arachnoid cysts are benign, cerebrospinal fluid-filled lesions that are frequently discovered incidentally on neuroimaging. Although most remain asymptomatic, large cysts may occasionally be associated with neurological symptoms due to mass effect or compression of adjacent structures.
- 16 February 2026
- Published by Springer Nature in Cureus
- Vol. 18 (2)
Open AccessGiant Arachnoid Cyst Presenting With Transient Facial Paresthesia: A Case Report
Arachnoid cysts are benign, cerebrospinal fluid-filled lesions that are frequently discovered incidentally on neuroimaging. Although most remain asymptomatic, large cysts may occasionally be associated with neurological symptoms due to mass effect or compression of adjacent structures.
- Open Access
- 15 January 2026
- Published by Springer Nature in Cureus
- Vol. 18 (1)
Presumed Very Late Relapse of Lepromatous Leprosy 35 Years After Treatment: A Diagnostic Challenge in a Non-endemic Setting
Leprosy is a chronic infectious disease caused by Mycobacterium leprae that primarily affects the skin and peripheral nerves. Although eliminated as a public health problem in many countries, it remains an important neglected tropical disease, with more than 174,000 new cases reported worldwide in 2023, predominantly in endemic regions such as India, Brazil, and Indonesia. We report a rare case of a presumed very late relapse of lepromatous leprosy occurring 35 years after treatment completion in a patient from a non-endemic European setting. The patient presented with progressive sensorimotor neuropathy, progressive deformities, and a chronic non-healing plantar ulcer. Historical records confirmed biopsy-proven lepromatous leprosy at the initial diagnosis, with documented cure following multidrug therapy. Current evaluation revealed the molecular detection of M. leprae in a skin biopsy, although histopathological features of active disease were not demonstrated. Given the absence of epidemiological risk factors for reinfection, the long disease-free interval, and the overall clinical and microbiological context, a very late relapse was considered the most plausible explanation. This case highlights the diagnostic challenges of leprosy in non-endemic settings and underscores the importance of long-term clinical vigilance and awareness of late complications.
- 15 January 2026
- Published by Springer Nature in Cureus
- Vol. 18 (1)
Open AccessPresumed Very Late Relapse of Lepromatous Leprosy 35 Years After Treatment: A Diagnostic Challenge in a Non-endemic Setting
Leprosy is a chronic infectious disease caused by Mycobacterium leprae that primarily affects the skin and peripheral nerves. Although eliminated as a public health problem in many countries, it remains an important neglected tropical disease, with more than 174,000 new cases reported worldwide in 2023, predominantly in endemic regions such as India, Brazil, and Indonesia. We report a rare case of a presumed very late relapse of lepromatous leprosy occurring 35 years after treatment completion in a patient from a non-endemic European setting. The patient presented with progressive sensorimotor neuropathy, progressive deformities, and a chronic non-healing plantar ulcer. Historical records confirmed biopsy-proven lepromatous leprosy at the initial diagnosis, with documented cure following multidrug therapy. Current evaluation revealed the molecular detection of M. leprae in a skin biopsy, although histopathological features of active disease were not demonstrated. Given the absence of epidemiological risk factors for reinfection, the long disease-free interval, and the overall clinical and microbiological context, a very late relapse was considered the most plausible explanation. This case highlights the diagnostic challenges of leprosy in non-endemic settings and underscores the importance of long-term clinical vigilance and awareness of late complications.
- Open Access
- 18 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Unmasking Sarcoidosis: Fever and Arthralgia Revealing an Underlying Granulomatous Disease
Sarcoidosis is a multisystem granulomatous inflammatory disease of unknown etiology, with a highly variable clinical presentation. Diagnosis can be particularly challenging, as the condition may manifest through a wide range of nonspecific symptoms, involve multiple organs, and lack pathognomonic findings. We describe the case of a previously healthy 65-year-old man who presented to the emergency department with fever and inflammatory large-joint arthralgias, without other associated symptoms. Physical examination was unremarkable, with no palpable lymphadenopathy, rash, or inflammatory signs in any joints examined. Initial laboratory evaluation showed a cholestatic pattern of liver enzymes, increased Creactive protein, and elevated angiotensin-converting enzyme. Chest computed tomography (CT) revealed mediastinal-hilar lymphadenopathy. During hospitalization, the patient maintained a persistent fever and arthralgias, prompting further evaluation with 18F-fluorodeoxyglucose positron emission tomographycomputed tomography (18F-FDG PET-CT), which demonstrated symmetric FDG uptake in thoracic lymph nodes and peripheral joints. Given the unexplained cholestatic pattern, a liver biopsy and lymph node biopsy were performed; there were no findings compatible with granulomas or malignancy. After excluding infectious, autoimmune, and neoplastic causes, the hypothesis of sarcoidosis persisted even with no definitive histological support, and the diagnosis was made through bronchoalveolar lavage (BAL), which revealed lymphocytic inflammation with a CD4/CD8 ratio of 7.3, highly compatible with sarcoidosis. Corticosteroid therapy was initiated with an excellent clinical response. This case highlights the importance of a systematic and comprehensive diagnostic approach when evaluating prolonged fever and inflammatory arthralgias. It underscores the need to consider sarcoidosis, even as a diagnosis of exclusion, particularly in atypical presentations with predominant joint involvement.
- 18 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Open AccessUnmasking Sarcoidosis: Fever and Arthralgia Revealing an Underlying Granulomatous Disease
Sarcoidosis is a multisystem granulomatous inflammatory disease of unknown etiology, with a highly variable clinical presentation. Diagnosis can be particularly challenging, as the condition may manifest through a wide range of nonspecific symptoms, involve multiple organs, and lack pathognomonic findings. We describe the case of a previously healthy 65-year-old man who presented to the emergency department with fever and inflammatory large-joint arthralgias, without other associated symptoms. Physical examination was unremarkable, with no palpable lymphadenopathy, rash, or inflammatory signs in any joints examined. Initial laboratory evaluation showed a cholestatic pattern of liver enzymes, increased Creactive protein, and elevated angiotensin-converting enzyme. Chest computed tomography (CT) revealed mediastinal-hilar lymphadenopathy. During hospitalization, the patient maintained a persistent fever and arthralgias, prompting further evaluation with 18F-fluorodeoxyglucose positron emission tomographycomputed tomography (18F-FDG PET-CT), which demonstrated symmetric FDG uptake in thoracic lymph nodes and peripheral joints. Given the unexplained cholestatic pattern, a liver biopsy and lymph node biopsy were performed; there were no findings compatible with granulomas or malignancy. After excluding infectious, autoimmune, and neoplastic causes, the hypothesis of sarcoidosis persisted even with no definitive histological support, and the diagnosis was made through bronchoalveolar lavage (BAL), which revealed lymphocytic inflammation with a CD4/CD8 ratio of 7.3, highly compatible with sarcoidosis. Corticosteroid therapy was initiated with an excellent clinical response. This case highlights the importance of a systematic and comprehensive diagnostic approach when evaluating prolonged fever and inflammatory arthralgias. It underscores the need to consider sarcoidosis, even as a diagnosis of exclusion, particularly in atypical presentations with predominant joint involvement.